Matsui T, Onishi T, Muramatsu M
Eur J Biochem. 1976 Dec 11;71(2):361-8. doi: 10.1111/j.1432-1033.1976.tb11122.x.
RNA polymerase I (or A) was extracted from nuclear, nucleolar and nucleoplasmic fractions, and resolved into IA and IB forms on a phosphocellulose column. During the course of cycloheximide treatment, the activity of RNA polymerase IB decreased in the nucleoli with concomitant increase in the nucleoplasmic fraction, suggesting strongly that cycloheximide induced specific leakage of IB enzyme from the nucleolus. The activity of IA enzyme did not change in the nucleoli. When nucleoli were incubated in the presence of actinomycin D, all the IA enzyme activity and approximately 30% of the total IB enzyme activity were released in the incubation medium, whereaa 70% of IB activity remained associated with the nucleolar pellet where no IA activity was detected. The enzyme which was released into the incubation medium was tentatively designated as free or unbound RNA polymerase I and that which was associated with the nucleolar pellet as template-bound enzyme. During the treatment with cycloheximide, the activity of bound enzyme, which contained exclusively IB form, decreased rapidly, with kinetics almost identical to that of nucleolar RNA synthesis in vivo. The activity of free enzyme did not change appreciably. At 2 h after partial hepatectomy, IB enzyme activity in the free RNA polymerase fraction increased to almost twice the control, while the bound enzyme activity did not increase appreciably until 4h of regeneration. Enhancement of nucleolar RNA synthesis in vivo was not apparent at 2 h but became significant by 4 h after partial hepatectomy. These results strongly suggest that (a) the above-mentioned procedure is actually fractionating RNA polymerase I into free and bound forms, (b) RNA polymerase IB is the transcriptionally active form in vivo, (c) RNA polymerase IB exists in excess in the nucleoli, but the amount of bound IB molecules, which are engaged in transcription in vivo, must be determined by some other factor(s) than the mere concentration of IB enzyme in the nucleolus, and (d) IA form is not an artifact of isolation but is always present in vivo at a certain amount, although the exact nature of this molecule is not known at present.
RNA聚合酶I(或A)从细胞核、核仁及核质部分中提取出来,并在磷酸纤维素柱上分离为IA和IB两种形式。在环己酰亚胺处理过程中,核仁中RNA聚合酶IB的活性下降,同时核质部分的活性增加,这强烈表明环己酰亚胺诱导了IB酶从核仁中特异性渗漏。IA酶在核仁中的活性没有变化。当核仁在放线菌素D存在的情况下孵育时,所有的IA酶活性以及大约30%的总IB酶活性释放到孵育培养基中,而70%的IB活性仍与未检测到IA活性的核仁沉淀相关。释放到孵育培养基中的酶被暂定为游离或未结合的RNA聚合酶I,与核仁沉淀相关的酶则为模板结合酶。在环己酰亚胺处理期间,仅包含IB形式的结合酶活性迅速下降,其动力学几乎与体内核仁RNA合成的动力学相同。游离酶的活性没有明显变化。部分肝切除术后2小时,游离RNA聚合酶部分中的IB酶活性增加到几乎是对照的两倍,而结合酶活性直到再生4小时才明显增加。部分肝切除术后2小时,体内核仁RNA合成的增强并不明显,但在4小时时变得显著。这些结果强烈表明:(a)上述方法实际上是将RNA聚合酶I分离为游离和结合形式;(b)RNA聚合酶IB是体内转录活性形式;(c)RNA聚合酶IB在核仁中过量存在,但参与体内转录的结合IB分子的数量必定由某些其他因素决定,而不仅仅取决于核仁中IB酶的浓度;(d)IA形式不是分离的假象,而是在体内始终以一定量存在,尽管目前尚不清楚该分子的确切性质。